A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
PHASE3CompletedINTERVENTIONAL
Enrollment
344
Participants
Timeline
Start Date
March 31, 1998
Study Completion Date
February 28, 2001
Conditions
DementiaAlzheimer DiseaseVascular Dementia
Interventions
DRUG
Risperidone
All Listed Sponsors
lead
Janssen-Cilag Pty Ltd
INDUSTRY
NCT00249158 - A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia | Biotech Hunter | Biotech Hunter